PLoS ONE (Jan 2017)

Genetic basis of calcifying cystic odontogenic tumors.

  • Akane Yukimori,
  • Yu Oikawa,
  • Kei-Ichi Morita,
  • Chi Thi Kim Nguyen,
  • Hiroyuki Harada,
  • Satoshi Yamaguchi,
  • Kou Kayamori,
  • Akira Yamaguchi,
  • Tohru Ikeda,
  • Kei Sakamoto

DOI
https://doi.org/10.1371/journal.pone.0180224
Journal volume & issue
Vol. 12, no. 6
p. e0180224

Abstract

Read online

Calcifying cystic odontogenic tumors (CCOTs) are benign cystic tumors that form abnormally keratinized ghost cells. Mutations in CTNNB1, which encodes beta-catenin, have been implicated in the development of these tumors, but a causal relationship has not been definitively established. Thus, mutational hot spots in 50 cancer genes were examined by targeted next-generation sequencing in 11 samples of CCOT. Mutations in CTNNB1, but not in other genes, were observed in 10 of 11 cases. These mutations constitutively activate beta-catenin signaling by abolishing the phosphorylation sites Asp32, Ser33, or Ser37, and are similar to those reported in pilomatrixoma and adamantinomatous craniopharyngioma. In contrast, BRAF or NRAS mutations were observed in 12 and two control samples of ameloblastoma, respectively. In HEK293 cells, overexpression of mutated CTNNB1 also upregulated hair keratin, a marker of ghost cells. Furthermore, ghost cells were present in two cases of ameloblastoma with BRAF and CTNNB1 mutations, indicating that ghost cells form due to mutations in CTNNB1. The data suggest that mutations in CTNNB1 are the major driver mutations of CCOT, and that CCOT is the genetic analog of pilomatrixoma and adamantinomatous craniopharyngioma in odontogenic tissue.